Quantum Pharmaceutical Aims To Accelerate Growth With Intention To Float
Quantum Pharma Plc, has announced its intention to ‘float’ shares in the Group on the London Stock Exchange (LSE) as part of plans to expand its offering for pharmacy, primary, secondary care and pharmaceutical companies.
In its ten year history, Quantum Pharma Plc has steadily grown its capabilities and services to the pharmaceutical wholesale and retail pharmacy, hospital, home care and care home markets. Milestones include the upcoming celebration of despatching its 2 millionth specials order, the opening of a state-of-the-art aseptic suite for the production of sterile injectable medicines in 2013, and the 30 per cent increase in users of its Biodose medicines delivery system in the past year.
Andrew Scaife, Chief Executive Officer of Quantum Pharma Plc, said: “Our decision to list the company makes strategic sense as we take Quantum to the next stage of its development. Having established our position as a market leader in the UK niche pharmaceutical market, becoming a Plc will afford us the opportunity to continue expanding to keep ahead of the rapidly changing needs of our customers, their patients and service users and the health service. We’re looking forward to an exciting future for our staff, customers and shareholders.”
Dealings in shares of Quantum Pharma Plc on the AIM (Alternative investment market) of the LSE are due to commence on 11th December 2014.
Posted by: Quantum Webmaster on 27th November 2014